In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives.
Yarong ZengFeihong ZouNing-Shao XiaShao-Wei LiPublished in: Expert review of vaccines (2023)
As the number of vaccine types increases, conventional aluminum adjuvants show limitations in effectively stimulating cellular immune responses, limiting their use in therapeutic vaccines for intracellular infections or tumors. In contrast, the use of conventional adjuvants as VADS to carry immunostimulatory molecules or deliver antigens can greatly enhance the immune boosting effect of classical adjuvants. A comprehensive understanding of the various delivery vehicles will further facilitate the development of vaccine adjuvant research.